Alfuzosin Hydrochloride
NDC Package 0440-5000-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Alfuzosin Hydrochloride is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Marketed by Liberty Pharmaceuticals, Inc., this product is identified by NDC 0440-5000 and is authorized under FDA application ANDA090284.

Identification & Billing

NDC Package Code
0440-5000-90
Package Description
90 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
0440-5000
11-Digit Billing Format
00440500090
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA
RxNorm Crosswalk
  • RxCUI: 861132 - alfuzosin HCl 10 MG 24HR Extended Release Oral Tablet
  • RxCUI: 861132 - 24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet
  • RxCUI: 861132 - alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Alfuzosin Hydrochloride
Dosage Form
-
Usage Information
Alfuzosin hydrochloride is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.

Regulatory & Marketing

Labeler Name
Liberty Pharmaceuticals, Inc.
FDA Application #
ANDA090284
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-02-2012
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0440-5000-90 identifies a specific commercial package of 90 tablet, extended release in 1 bottle of Alfuzosin Hydrochloride, labeled by Liberty Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Liberty Pharmaceuticals, Inc. on October 02, 2012. The current certification is valid through December 31, 2018.

How is this Liberty Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00440500090. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0440-5000-90
11-Digit CMS (5-4-2)
00440-5000-90

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.